Financial reports
10-Q
2023 Q2
Quarterly report
21 Aug 23
NT 10-Q
Notice of late quarterly filing
14 Aug 23
10-Q
2023 Q1
Quarterly report
15 May 23
10-K
2022 FY
Annual report
31 Mar 23
10-Q
2022 Q3
Quarterly report
21 Nov 22
NT 10-Q
Notice of late quarterly filing
14 Nov 22
10-Q
2022 Q2
Quarterly report
11 Aug 22
10-Q
2022 Q1
Quarterly report
13 May 22
10-K
2021 FY
Annual report
31 Mar 22
10-Q
2021 Q3
Quarterly report
12 Nov 21
Current reports
8-K
Changes in Registrant's Certifying Accountant
16 Nov 22
8-K
Changes in Registrant's Certifying Accountant
13 Oct 22
8-K/A
Other Events
12 Oct 21
8-K
Other Events
12 Oct 21
8-K
Entry into a Material Definitive Agreement
5 Oct 21
8-K
Entry into a Material Definitive Agreement
21 Jun 21
8-K
Results of Operations and Financial Condition
1 Apr 21
8-K
Entry into a Material Definitive Agreement
12 Jan 21
8-K
Entry into a Material Definitive Agreement
27 Nov 20
8-K
Entry into a Material Definitive Agreement
29 Oct 20
Registration and prospectus
424B3
Prospectus supplement
9 Dec 21
S-1/A
IPO registration (amended)
3 Dec 21
D
$600K in debt / options / securities to be acquired, sold $600K, 2 investors
7 Jul 21
S-1
IPO registration
29 Apr 21
D
$0 in equity / options, 1 investor
2 Feb 21
D
$500K in debt / options / securities to be acquired, sold $500K, 1 investor
2 Feb 21
D
$600K in debt / options / securities to be acquired, sold $600K, 3 investors
2 Feb 21
D
$320K in debt / securities to be acquired, sold $320K, 4 investors
27 Sep 17
D/A
$300K in equity / options / securities to be acquired, sold $290.43K, 21 investors
27 Apr 17
D
$300K in equity / options / securities to be acquired, sold $200K, 16 investors
3 Apr 17
Proxies
DEF 14C
Information statement
3 Sep 21
PRE 14C
Preliminary information
25 Aug 21
DEF 14C
Information statement
4 Nov 20
PRER14C
Preliminary revised information
2 Nov 20
PRE 14C
Preliminary information
16 Oct 20
PRE 14A
Preliminary proxy
15 Oct 20
DEF 14C
Information statement
27 May 20
PRE 14C
Preliminary information
15 May 20
DEF 14C
Information statement
22 Jan 19
PRE 14C
Preliminary information
10 Jan 19
Other
EFFECT
Notice of effectiveness
10 Dec 21
CORRESP
Correspondence with SEC
8 Dec 21
UPLOAD
Letter from SEC
4 May 21
UPLOAD
Letter from SEC
13 Nov 20
UPLOAD
Letter from SEC
2 Nov 20
CORRESP
Correspondence with SEC
2 Nov 20
EFFECT
Notice of effectiveness
31 Jan 17
CORRESP
Correspondence with SEC
30 Jan 17
CORRESP
Correspondence with SEC
27 Jan 17
UPLOAD
Letter from SEC
26 Jan 17
Ownership
SC 13G/A
SABBY MANAGEMENT, LLC
10 Jan 23
SC 13G/A
Inspyr Therapeutics, Inc.
21 Jan 20
SC 13G
Inspyr Therapeutics, Inc.
26 Nov 18
4
Bo Jesper Hansen
15 Aug 17
3
John Robison Montgomery
15 Aug 17
4
PETER E GREBOW
2 Aug 17
4
SCOTT VARDE OGILVIE
6 Mar 17
SC 13G/A
Inspyr Therapeutics, Inc.
9 Jan 17
4
Bo Jesper Hansen
28 Oct 16
3
Claire Thom
24 Oct 16